XML 36 R26.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Stockholders’ Equity (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Schedule of Stock Option Transactions | Stock option transactions under the Company’s Plan for the nine months ended September 30, 2022 and the year ended December 31, 2021 are summarized as follows: Schedule of Stock Option Transactions
Stock Options |  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |  |  | Weighted Average Grant Date Fair Value |
Outstanding - December 31, 2020 |  |  | 17,004 |  |  | $ | 16.00 |  |  |  | 6.16 |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - December 31, 2020 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - December 31, 2020 |  |  | 17,004 |  |  | $ | 16.00 |  |  |  | 6.16 |  |  | $ | - |  |  | $ | - |
Granted |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  | $ | - |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - December 31, 2021 |  |  | 17,004 |  |  | $ | 16.00 |  |  |  | 5.16 |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - December 31, 2021 |  |  | 3,401 |  |  | $ | 16.00 |  |  |  | 5.16 |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - December 31, 2021 |  |  | 13,603 |  |  | $ | 16.00 |  |  |  | 5.16 |  |  | $ | - |  |  | $ | - |
Granted |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  | $ | - |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - September 30, 2022 |  |  | 17,004 |  |  | $ | 16.00 |  |  |  | 4.42 |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - September 30, 2022 |  |  | 6,801 |  |  | $ | 16.00 |  |  |  | 4.42 |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - September 30, 2022 |  |  | 10,202 |  |  | $ | 16.00 |  |  |  | 4.42 |  |  | $ | - |  |  | $ | - |
Schedule of Warrants Activity | Warrant activity for the nine months ended September 30, 2022 and the year ended December 31, 2021 are summarized as follows: Schedule of Warrants Activity
|  |  |  |  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  |  |  |  |  | Average |  |  |  |
|  |  |  |  |  | Weighted |  |  | Remaining |  |  | Aggregate |
|  |  | Number of |  |  | Average |  |  | Contractual |  |  | Intrinsic |
Warrants |  |  | Warrants |  |  | Exercise Price |  |  | Term (Years) |  |  | Value |
Outstanding - December 31, 2020 |  |  |  | 194,317 |  |  | $ | 32.50 |  |  |  | 1.52 |  |  | $ | - |
Vested and Exercisable - December 31, 2020 |  |  |  | 194,317 |  |  | $ | 32.50 |  |  |  | 1.52 |  |  | $ | - |
Granted |  |  |  | 5,935,450 |  |  | $ | 8.01 |  |  |  | - |  |  |  | - |
Exercised |  |  |  | (2,133 | ) |  | $ | 12.50 |  |  |  | - |  |  |  | - |
Cancelled/Forfeited |  |  |  | (44,650 | ) |  | $ | 23.49 |  |  |  | - |  |  |  | - |
Outstanding - December 31, 2021 |  |  |  | 6,082,984 |  |  | $ | 8.68 |  |  |  | 2.93 |  |  | $ | - |
Vested and Exercisable - December 31, 2021 |  |  |  | 5,852,984 |  |  | $ | 8.70 |  |  |  | 2.85 |  |  | $ | - |
Unvested - December 31, 2021 |  |  |  | 230,000 |  |  | $ | 8.00 |  |  |  | 4.85 |  |  | $ | - |
Granted |  |  |  | 153,000 |  |  | $ | 4.73 |  |  |  | - |  |  |  |  |
Exercised |  |  |  | (498,750 | ) |  | $ | 8.00 |  |  |  | - |  |  |  |  |
Cancelled/Forfeited |  |  |  | (88,671 | ) |  | $ | 40.04 |  |  |  | - |  |  |  |  |
Outstanding - September 30, 2022 |  |  |  | 5,648,563 |  |  | $ | 8.14 |  |  |  | 2.10 |  |  | $ | - |
Vested and Exercisable - September 30, 2022 |  |  |  | 5,648,563 |  |  | $ | 8.14 |  |  |  | 2.10 |  |  | $ | - |
Unvested and non-exercisable - September 30, 2022 |  |  |  | - |  |  | $ | - |  |  |  | 0.00 |  |  | $ | - |
Warrant One [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Schedule of Fair Value of Warrants | Schedule of Fair Value of Warrants
Expected term (years) |  | 5
Expected volatility |  | 118%
Expected dividends |  | 0%
Risk free interest rate |  | 0.53%
Warrant Two [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Schedule of Fair Value of Warrants | Fair value of the warrants was determined using a Black-Scholes option pricing model with the following inputs: Schedule of Fair Value of Warrants
Expected term (years) |  | 3
Expected volatility |  | 118%
Expected dividends |  | 0%
Risk free interest rate |  | 0.53%
Warrant Three [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Schedule of Fair Value of Warrants | The fair value of these warrants was determined using a Black-Scholes option pricing model with the following inputs: Schedule of Fair Value of Warrants
Expected term (years) |  |  | 3 years |
Expected volatility |  |  | 119% - 120 | %
Expected dividends |  |  | 0 | %
Risk free interest rate |  |  | 2.45% - 2.80 | %
Warrant Four [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Schedule of Fair Value of Warrants | The fair value of these warrants was determined using a Black-Scholes option pricing model with the following inputs: Schedule of Fair Value of Warrants
Expected term (years) |  |  | 3 years |
Expected volatility |  |  | 120 | %
Expected dividends |  |  | 0 | %
Risk free interest rate |  |  | 2.71 | %
Warrant Five [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Schedule of Fair Value of Warrants | The fair value of these warrants was determined using a Black-Scholes option pricing model with the following inputs: Schedule of Fair Value of Warrants
Expected term (years) |  |  | 3 years |
Expected volatility |  |  | 119 | %
Expected dividends |  |  | 0 | %
Risk free interest rate |  |  | 4.25 | %
Warrant Six [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Schedule of Fair Value of Warrants | The fair value of these warrants was determined using a Black-Scholes option pricing model with the following inputs: Schedule of Fair Value of Warrants
Expected term (years) |  | 3 - 5
Expected volatility |  | 119% - 146%
Expected dividends |  | 0%
Risk free interest rate |  | 0.07% - 1.15%

X
- Definition Schedule of Fair Value of Warrants [Table Text Block] + References No definition available. + Details
Name: | SURG_ScheduleOfFairValueOfTheWarrantsTableTextBlock
Namespace Prefix: | SURG_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=SURG_WarrantOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=SURG_WarrantTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=SURG_WarrantThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=SURG_WarrantFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=SURG_WarrantFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=SURG_WarrantSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |